NCT04192825 Analysis of Therapeutic Management Strategies for Anal Suppurations of Crohn's Disease
| NCT ID | NCT04192825 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Rennes University Hospital |
| Condition | Crohn Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 440 participants |
| Start Date | 2020-02-03 |
| Primary Completion | 2025-08-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 440 participants in total. It began in 2020-02-03 with a primary completion date of 2025-08-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Determine the optimal therapeutic combination associated with complete clinical and anatomical remission of anal suppurations of Crohn's disease at 12 months.
Eligibility Criteria
Inclusion Criteria: * Persons over 18 years of age * People suffering from anal suppuration of Crohn's disease for whom a drainage procedure is planned. * Person who has received written and oral information about the protocol and has not expressed opposition to participate in the study. Exclusion Criteria: * No one who is unable to have an anesthetic, structural or psychological examination by MRI and/or surgery. * Person planning a planned absence that could hinder participation in the research (travel abroad, relocation, impending transfer); * Person with an associated pathology that is a priority for care; * Vulnerable person (minors, persons under guardianship or curatorship, or deprived of their liberty by a judicial or administrative decision
Contact & Investigator
Laurent SIPROUDHIS, PH-PD
PRINCIPAL INVESTIGATOR
Rennes University Hospital
Frequently Asked Questions
Who can join the NCT04192825 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Crohn Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04192825 currently recruiting?
Yes, NCT04192825 is actively recruiting participants. Contact the research team at kristell.coat@chu-rennes.fr for enrollment information.
Where is the NCT04192825 trial being conducted?
This trial is being conducted at Rennes, France.
Who is sponsoring the NCT04192825 clinical trial?
NCT04192825 is sponsored by Rennes University Hospital. The principal investigator is Laurent SIPROUDHIS, PH-PD at Rennes University Hospital. The trial plans to enroll 440 participants.